Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.

In five patients with venous thromboembolic disease treated with recombinant tissue-type plasminogen activator (rt-PA), there was a marked increase in the mean concentrations of fibrinopeptide A (from 0.6 to 5.9 nM; P less than 0.0001) and desarginine fibrinopeptide B (from 5.6 nM to 24.1 nM; P less...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Weitz, J I, Cruickshank, M K, Thong, B, Leslie, B, Levine, M N, Ginsberg, J, Eckhardt, T
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1988
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442740/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3141481/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113783
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!